The Associated Press Wednesday did a rather dire story on almost-complete studies on three potential drugs for Alzheimer’s disease. The gist of the article is quite simple: If these drugs don’t do well in their late-stage trials, several pharmaceutical companies may give up on finding a cure for Alzheimer’s. AP..
Read more
Researchers for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) plan to map the DNA of 800 people who are taking part in a study of the causes of memory and cognitive loss, according to various press reports this week. The University of California at Los Angeles (UCLA) issued a press release..
Read more
It looks like the less time a person with Alzheimer’s disease spends in the hospital, the better, according to a new study by Harvard University. The study found that being hospitalized begins a downward trend for many who suffer from Alzheimer’s disease, speeding their moves into nursing homes, and even..
Read more
This may be a little technical, but bear with me here. It looks like the National Institutes of Health (NIH) has done some interesting Alzeimer’s disease research. As the NIH explains in a recent press release (which this blog is based on), variants of the ApoE gene are strongly associated..
Read more
Federal health officials Tuesday unveiled details of the Obama administration’s ambitious national plan to fight Alzheimer’s disease, an effort that includes a $100 million landmark trial of a drug that will try to prevent those at high risk for the ailment from getting it. http://www.hhs.gov/news/press/2012pres/05/20120515a.html Health and Human Services Secretary..
Read more
In what could be a big breakthrough, Eli Lilly & Co. has won approval from federal regulators for an imaging test that detects the brain plaque that’s a hallmark of Alzheimer’s disease. The drug maker received the go-ahead from the U.S. Food and Drug Administration (FDA) late last Friday, and..
Read more
Microsoft co-founder Paul Allen, whose mother has Alzheimer’s disease, is committing an additional $300 million to brain research. In a press release, the Allen Institute for Brain Science said that Allen’s latest contribution will allow the organization to significantly expand its scientific programs. Like his fellow Microsoft co-founder, Bill Gates,..
Read more
The story of Charles D. Snelling is a sad lesson in how caring for a loved one with Alzheimer’s disease can be overwhelming — even for those with the best of intentions. And yes, even for those who adored the person who contracts this disease. Back in December, Snelling wrote..
Read more
Letting Alzheimer’s patients do what they want, within reason, has proven to be a successful treatment strategy for a Phoenix nursing home, according to The New York Times. http://www.nytimes.com/2011/01/01/health/01care.html?_r=1&hp The Times on Saturday did a Page One story, with the headline “Giving Alzheimer’s Patients Their Way, Even Doses of Chocolate,” about the..
Read more
There has been news in recent weeks of two tests that appear to positively identify Alzheimer’s disease long before its symptoms appear: PET scans of Alzheimer’s plaque in the brain and tests of spinal fluid. But as The New York Times pointed out in a Page One story Sunday, scientists still don’t..
Read more
Brain Injury Law Group
Attorney Gordon S. Johnson, Jr.
212 Whitetail Run Ln.
Sheboygan, Wisconsin
800-992-9447
Email Us
ADVERTISING MATERIAL
Brought to you by The Brain Injury Law Group, SC. The materials on this web page are provided purely for informational purposes. They are not intended to be legal advice. This information is intended, but not promised or guaranteed, to be correct, complete, and current. While this page is not intended to be a source of advertising, solicitation or legal advice, it could be deemed to be such.
TBI Voices TBI Law
Print Friendly Version
Save Page as PDF